Treatment of malignant pleural mesothelioma with liposomized doxorubicine: prolonged time to progression and good survival. A Nordic study. [electronic resource]
Producer: 20100730Description: 80-5 p. digitalISSN:- 1752-699X
- Adult
- Aged
- Aged, 80 and over
- Antibiotics, Antineoplastic -- administration & dosage
- Blood -- drug effects
- Disease Progression
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Erythema -- chemically induced
- Female
- Humans
- Liposomes
- Male
- Mesothelioma -- drug therapy
- Middle Aged
- Pleural Neoplasms -- drug therapy
- Quality of Life
- Survival Rate
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.